A detailed history of Forvis Wealth Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 26,311 shares of BMY stock, worth $1.55 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,311
Previous 26,289 0.08%
Holding current value
$1.55 Million
Previous $1.09 Million 24.75%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $872 - $1,138
22 Added 0.08%
26,311 $1.36 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $18,716 - $24,640
465 Added 1.8%
26,289 $1.09 Million
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $60,502 - $68,598
-1,261 Reduced 4.66%
25,824 $1.4 Million
Q4 2023

Jan 11, 2024

SELL
$48.48 - $57.85 $56,818 - $67,800
-1,172 Reduced 4.15%
27,085 $1.39 Million
Q3 2023

Oct 25, 2023

BUY
$57.89 - $64.73 $141,598 - $158,329
2,446 Added 9.48%
28,257 $1.64 Million
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $722,981 - $802,757
11,348 Added 78.46%
25,811 $1.65 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $19,187 - $21,762
-292 Reduced 1.98%
14,463 $1 Million
Q4 2022

Feb 02, 2023

SELL
$68.48 - $81.09 $30,542 - $36,166
-446 Reduced 2.93%
14,755 $1.06 Million
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $52 - $30,736
400 Added 2.7%
15,201 $1.08 Million
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $231,076 - $254,496
3,182 Added 27.39%
14,801 $1.14 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $2,705 - $3,243
-44 Reduced 0.38%
11,619 $849,000
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $58,403 - $68,084
1,089 Added 10.3%
11,663 $727,000
Q3 2021

Oct 14, 2021

SELL
$59.17 - $69.31 $26,744 - $31,328
-452 Reduced 4.1%
10,574 $626,000
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $203,250 - $221,339
-3,283 Reduced 22.94%
11,026 $737,000
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $776,107 - $872,892
-13,079 Reduced 47.75%
14,309 $903,000
Q4 2020

Jan 22, 2021

BUY
$57.74 - $65.43 $495,293 - $561,258
8,578 Added 45.6%
27,388 $1.7 Million
Q3 2020

Nov 05, 2020

BUY
$57.43 - $63.64 $61,852 - $68,540
1,077 Added 6.07%
18,810 $1.13 Million
Q2 2020

Jul 15, 2020

SELL
$54.82 - $64.09 $151,632 - $177,272
-2,766 Reduced 13.49%
17,733 $1.04 Million
Q1 2020

Apr 10, 2020

SELL
$46.4 - $67.43 $54,937 - $79,837
-1,184 Reduced 5.46%
20,499 $1.14 Million
Q4 2019

Jan 13, 2020

BUY
$49.21 - $64.19 $238,963 - $311,706
4,856 Added 28.86%
21,683 $1.39 Million
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $54,317 - $64,401
1,270 Added 8.16%
16,827 $853,000
Q2 2019

Jul 10, 2019

SELL
$44.62 - $49.34 $124,222 - $137,362
-2,784 Reduced 15.18%
15,557 $706,000
Q1 2019

Apr 10, 2019

SELL
$45.12 - $53.8 $171,771 - $204,816
-3,807 Reduced 17.19%
18,341 $875,000
Q4 2018

Jan 15, 2019

BUY
$48.76 - $63.23 $39,739 - $51,532
815 Added 3.82%
22,148 $1.15 Million
Q3 2018

Oct 09, 2018

BUY
$55.19 - $62.25 $433,572 - $489,036
7,856 Added 58.29%
21,333 $1.32 Million
Q2 2018

Jul 13, 2018

SELL
$50.53 - $62.98 $9,954 - $12,407
-197 Reduced 1.44%
13,477 $746,000
Q1 2018

May 25, 2018

BUY
$59.92 - $68.98 $2,636 - $3,035
44 Added 0.32%
13,674 $865,000
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $53,928 - $62,082
-900 Reduced 6.19%
13,630 $713,000
Q4 2017

Jan 18, 2018

SELL
$59.94 - $65.35 $15,404 - $16,794
-257 Reduced 1.74%
14,530 $890,000
Q3 2017

Oct 13, 2017

BUY
$55.23 - $63.74 $816,686 - $942,523
14,787
14,787 $943,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Forvis Wealth Advisors, LLC Portfolio

Follow Forvis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.